HC Wainwright reaffirmed their buy rating on shares of Palatin Technologies (NYSEAMERICAN:PTN – Free Report) in a research note released on Thursday morning, Benzinga reports. The firm currently has a $17.00 price target on the biopharmaceutical company’s stock.
Palatin Technologies Stock Up 2.9 %
Shares of PTN stock opened at $2.11 on Thursday. Palatin Technologies has a fifty-two week low of $1.43 and a fifty-two week high of $5.65. The company has a market capitalization of $34.06 million, a P/E ratio of -0.82 and a beta of 0.86.
Palatin Technologies (NYSEAMERICAN:PTN – Get Free Report) last posted its quarterly earnings results on Wednesday, February 14th. The biopharmaceutical company reported ($0.56) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.36). The business had revenue of $2.03 million during the quarter, compared to analyst estimates of $2.28 million. Palatin Technologies had a negative return on equity of 583.06% and a negative net margin of 445.12%. During the same quarter last year, the firm earned ($0.13) EPS. As a group, research analysts predict that Palatin Technologies will post -2.36 EPS for the current year.
Institutional Trading of Palatin Technologies
About Palatin Technologies
Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder.
Read More
- Five stocks we like better than Palatin Technologies
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- MarketBeat Week in Review – 4/29 – 5/3
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What Are Growth Stocks and Investing in Them
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.